US FDA revokes authorization for four COVID treatments

US FDA revokes authorization for four COVID treatments

(Reuters) – The U.S. Food and Drug Administration said on Monday it had revoked the emergency use authorization for four COVID-19 treatments, including those from Eli Lilly (NYSE:LLY) and Regeneron…
Mizuho raises UGI price target to $33

Mizuho raises UGI price target to $33

Investing.com —  Mizuho (NYSE:MFG) reiterated its “outperform” rating on UGI Corporation (NYSE:UGI) and raised its price target to $33, citing potential value unlock through operational improvements and growth in its…
US House committee targets another investor climate group

US House committee targets another investor climate group

By Ross Kerber (Reuters) – The Republican-led U.S. House of Representatives Judiciary Committee is seeking information from some 60 U.S. asset managers about their involvement with an investor climate group,…